UniProt ID | UBP1_HUMAN | |
---|---|---|
UniProt AC | O94782 | |
Protein Name | Ubiquitin carboxyl-terminal hydrolase 1 | |
Gene Name | USP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 785 | |
Subcellular Localization | Nucleus . | |
Protein Description | Negative regulator of DNA damage repair which specifically deubiquitinates monoubiquitinated FANCD2. [PubMed: 15694335 Also involved in PCNA-mediated translesion synthesis (TLS) by deubiquitinating monoubiquitinated PCNA] | |
Protein Sequence | MPGVIPSESNGLSRGSPSKKNRLSLKFFQKKETKRALDFTDSQENEEKASEYRASEIDQVVPAAQSSPINCEKRENLLPFVGLNNLGNTCYLNSILQVLYFCPGFKSGVKHLFNIISRKKEALKDEANQKDKGNCKEDSLASYELICSLQSLIISVEQLQASFLLNPEKYTDELATQPRRLLNTLRELNPMYEGYLQHDAQEVLQCILGNIQETCQLLKKEEVKNVAELPTKVEEIPHPKEEMNGINSIEMDSMRHSEDFKEKLPKGNGKRKSDTEFGNMKKKVKLSKEHQSLEENQRQTRSKRKATSDTLESPPKIIPKYISENESPRPSQKKSRVKINWLKSATKQPSILSKFCSLGKITTNQGVKGQSKENECDPEEDLGKCESDNTTNGCGLESPGNTVTPVNVNEVKPINKGEEQIGFELVEKLFQGQLVLRTRCLECESLTERREDFQDISVPVQEDELSKVEESSEISPEPKTEMKTLRWAISQFASVERIVGEDKYFCENCHHYTEAERSLLFDKMPEVITIHLKCFAASGLEFDCYGGGLSKINTPLLTPLKLSLEEWSTKPTNDSYGLFAVVMHSGITISSGHYTASVKVTDLNSLELDKGNFVVDQMCEIGKPEPLNEEEARGVVENYNDEEVSIRVGGNTQPSKVLNKKNVEAIGLLGGQKSKADYELYNKASNPDKVASTAFAENRNSETSDTTGTHESDRNKESSDQTGINISGFENKISYVVQSLKEYEGKWLLFDDSEVKVTEEKDFLNSLSPSTSPTSTPYLLFYKKL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MPGVIPSESNGLSR -CCCCCCCCCCCCCC | 42.40 | 23927012 | |
9 | Phosphorylation | PGVIPSESNGLSRGS CCCCCCCCCCCCCCC | 40.30 | 23401153 | |
13 | Phosphorylation | PSESNGLSRGSPSKK CCCCCCCCCCCCCCC | 35.67 | 23401153 | |
16 | Phosphorylation | SNGLSRGSPSKKNRL CCCCCCCCCCCCCCC | 25.53 | 25159151 | |
18 | Phosphorylation | GLSRGSPSKKNRLSL CCCCCCCCCCCCCCH | 58.94 | 30108239 | |
33 | Phosphorylation | KFFQKKETKRALDFT HHHCHHHHHHHCCCC | 34.41 | - | |
40 | Phosphorylation | TKRALDFTDSQENEE HHHHCCCCCCHHHHH | 34.11 | 27732954 | |
42 | Phosphorylation | RALDFTDSQENEEKA HHCCCCCCHHHHHHH | 36.01 | 17525332 | |
48 | Ubiquitination | DSQENEEKASEYRAS CCHHHHHHHHHHHHH | 51.54 | 24816145 | |
50 | Phosphorylation | QENEEKASEYRASEI HHHHHHHHHHHHHHH | 46.35 | 23312004 | |
52 | Phosphorylation | NEEKASEYRASEIDQ HHHHHHHHHHHHHHH | 14.69 | 23312004 | |
55 | Phosphorylation | KASEYRASEIDQVVP HHHHHHHHHHHHHCC | 26.53 | 22167270 | |
66 | Phosphorylation | QVVPAAQSSPINCEK HHCCHHHCCCCCCCH | 33.10 | 23401153 | |
67 | Phosphorylation | VVPAAQSSPINCEKR HCCHHHCCCCCCCHH | 20.09 | 29255136 | |
73 | Ubiquitination | SSPINCEKRENLLPF CCCCCCCHHCCCCCC | 68.18 | 21963094 | |
110 | Ubiquitination | PGFKSGVKHLFNIIS CCHHHHHHHHHHHHH | 37.81 | 29967540 | |
124 | Sumoylation | SRKKEALKDEANQKD HHHHHHHHHHHHHHC | 61.65 | - | |
124 | Sumoylation | SRKKEALKDEANQKD HHHHHHHHHHHHHHC | 61.65 | - | |
130 | Acetylation | LKDEANQKDKGNCKE HHHHHHHHCCCCCCH | 62.30 | 19828857 | |
224 | Ubiquitination | LLKKEEVKNVAELPT HHCHHHHCCHHHCCC | 49.32 | 29967540 | |
232 | Sumoylation | NVAELPTKVEEIPHP CHHHCCCCHHHCCCC | 45.79 | - | |
232 | Ubiquitination | NVAELPTKVEEIPHP CHHHCCCCHHHCCCC | 45.79 | 29967540 | |
232 | Sumoylation | NVAELPTKVEEIPHP CHHHCCCCHHHCCCC | 45.79 | - | |
248 | Phosphorylation | EEMNGINSIEMDSMR HHHCCCCCCCHHHHC | 20.29 | 20068231 | |
253 | Phosphorylation | INSIEMDSMRHSEDF CCCCCHHHHCCCHHH | 19.19 | 26074081 | |
257 | Phosphorylation | EMDSMRHSEDFKEKL CHHHHCCCHHHHHHC | 28.61 | 26074081 | |
273 | Phosphorylation | KGNGKRKSDTEFGNM CCCCCCCCCCCCHHH | 54.52 | 28985074 | |
275 | Phosphorylation | NGKRKSDTEFGNMKK CCCCCCCCCCHHHHH | 40.06 | 29449344 | |
283 | Ubiquitination | EFGNMKKKVKLSKEH CCHHHHHHHHHCHHH | 38.80 | - | |
285 | Ubiquitination | GNMKKKVKLSKEHQS HHHHHHHHHCHHHHH | 56.79 | - | |
292 | Phosphorylation | KLSKEHQSLEENQRQ HHCHHHHHHHHHHHH | 39.39 | 30576142 | |
307 | Phosphorylation | TRSKRKATSDTLESP HHHHHHHCCCCCCCC | 30.12 | 23684312 | |
308 | Phosphorylation | RSKRKATSDTLESPP HHHHHHCCCCCCCCC | 33.20 | 30576142 | |
310 | Phosphorylation | KRKATSDTLESPPKI HHHHCCCCCCCCCCC | 31.99 | 27794612 | |
313 | Phosphorylation | ATSDTLESPPKIIPK HCCCCCCCCCCCCCH | 50.00 | 29255136 | |
321 | Phosphorylation | PPKIIPKYISENESP CCCCCCHHCCCCCCC | 12.34 | 29396449 | |
323 | Phosphorylation | KIIPKYISENESPRP CCCCHHCCCCCCCCC | 31.14 | 25262027 | |
327 | Phosphorylation | KYISENESPRPSQKK HHCCCCCCCCCCCCC | 37.48 | 22167270 | |
331 | Phosphorylation | ENESPRPSQKKSRVK CCCCCCCCCCCCHHH | 56.78 | 22167270 | |
343 | Ubiquitination | RVKINWLKSATKQPS HHHHHHHHHHCCCCC | 29.65 | 29967540 | |
344 | Phosphorylation | VKINWLKSATKQPSI HHHHHHHHHCCCCCH | 38.71 | 26074081 | |
346 | Phosphorylation | INWLKSATKQPSILS HHHHHHHCCCCCHHH | 36.98 | 26074081 | |
347 | Acetylation | NWLKSATKQPSILSK HHHHHHCCCCCHHHH | 60.99 | 25953088 | |
350 | Phosphorylation | KSATKQPSILSKFCS HHHCCCCCHHHHHHH | 33.40 | 29978859 | |
353 | Phosphorylation | TKQPSILSKFCSLGK CCCCCHHHHHHHCCC | 23.24 | 26074081 | |
360 | Acetylation | SKFCSLGKITTNQGV HHHHHCCCCCCCCCC | 42.02 | 25953088 | |
360 | Ubiquitination | SKFCSLGKITTNQGV HHHHHCCCCCCCCCC | 42.02 | - | |
368 | Ubiquitination | ITTNQGVKGQSKENE CCCCCCCCCCCCCCC | 59.04 | 29967540 | |
387 | Phosphorylation | EDLGKCESDNTTNGC HHHCCCCCCCCCCCC | 45.70 | 26074081 | |
390 | Phosphorylation | GKCESDNTTNGCGLE CCCCCCCCCCCCCCC | 26.99 | 23663014 | |
391 | Phosphorylation | KCESDNTTNGCGLES CCCCCCCCCCCCCCC | 35.55 | 23663014 | |
398 | Phosphorylation | TNGCGLESPGNTVTP CCCCCCCCCCCEECC | 43.05 | 23663014 | |
402 | Phosphorylation | GLESPGNTVTPVNVN CCCCCCCEECCCCHH | 31.50 | 25850435 | |
404 | Phosphorylation | ESPGNTVTPVNVNEV CCCCCEECCCCHHHC | 21.34 | 26074081 | |
457 | Phosphorylation | REDFQDISVPVQEDE HHHHCCCCCCCCHHH | 28.76 | 29978859 | |
466 | Phosphorylation | PVQEDELSKVEESSE CCCHHHHHCHHCCCC | 32.38 | 28464451 | |
471 | Phosphorylation | ELSKVEESSEISPEP HHHCHHCCCCCCCCC | 21.55 | 30266825 | |
472 | Phosphorylation | LSKVEESSEISPEPK HHCHHCCCCCCCCCC | 42.08 | 30266825 | |
475 | Phosphorylation | VEESSEISPEPKTEM HHCCCCCCCCCCHHH | 21.11 | 29255136 | |
483 | Ubiquitination | PEPKTEMKTLRWAIS CCCCHHHHHHHHHHH | 37.87 | - | |
503 | Ubiquitination | ERIVGEDKYFCENCH HHHHCCCCEECCCCC | 35.60 | - | |
523 | Ubiquitination | ERSLLFDKMPEVITI HHHHHHCCCCCEEEE | 49.36 | - | |
529 | Phosphorylation | DKMPEVITIHLKCFA CCCCCEEEEEEHHHH | 13.91 | 20068231 | |
551 | Ubiquitination | CYGGGLSKINTPLLT EECCCHHCCCCCCCC | 45.05 | 21963094 | |
554 | Phosphorylation | GGLSKINTPLLTPLK CCHHCCCCCCCCCCE | 20.84 | 29978859 | |
558 | Phosphorylation | KINTPLLTPLKLSLE CCCCCCCCCCEECHH | 33.97 | 29978859 | |
610 | Ubiquitination | LNSLELDKGNFVVDQ CCCCCCCCCCEEEEC | 69.27 | 29967540 | |
623 | Ubiquitination | DQMCEIGKPEPLNEE ECCCCCCCCCCCCHH | 52.44 | 29967540 | |
656 | Ubiquitination | GGNTQPSKVLNKKNV CCCCCCCCCCCCCCH | 58.38 | 29967540 | |
675 | Ubiquitination | LLGGQKSKADYELYN ECCCCCCHHHHHHHH | 52.92 | 29967540 | |
678 | Phosphorylation | GQKSKADYELYNKAS CCCCHHHHHHHHHCC | 16.82 | - | |
681 | Phosphorylation | SKADYELYNKASNPD CHHHHHHHHHCCCHH | 11.59 | - | |
683 | Ubiquitination | ADYELYNKASNPDKV HHHHHHHHCCCHHHH | 39.37 | 29967540 | |
689 | Ubiquitination | NKASNPDKVASTAFA HHCCCHHHHHHHHHH | 40.74 | 21963094 | |
689 | Acetylation | NKASNPDKVASTAFA HHCCCHHHHHHHHHH | 40.74 | 26051181 | |
716 | Acetylation | THESDRNKESSDQTG CCHHHCCCCCCCCCC | 60.92 | 19814743 | |
716 | Ubiquitination | THESDRNKESSDQTG CCHHHCCCCCCCCCC | 60.92 | 29967540 | |
722 | Phosphorylation | NKESSDQTGINISGF CCCCCCCCCCCCHHH | 45.05 | 29978859 | |
727 | Phosphorylation | DQTGINISGFENKIS CCCCCCCHHHHHHHH | 32.70 | 25159151 | |
732 | Ubiquitination | NISGFENKISYVVQS CCHHHHHHHHHHHHH | 26.32 | 32015554 | |
741 | Ubiquitination | SYVVQSLKEYEGKWL HHHHHHHHHHCCEEE | 64.59 | 21906983 | |
746 | Ubiquitination | SLKEYEGKWLLFDDS HHHHHCCEEEEECCC | 23.80 | 22817900 | |
756 | Ubiquitination | LFDDSEVKVTEEKDF EECCCCCEEEECHHH | 39.11 | 22817900 | |
761 | Ubiquitination | EVKVTEEKDFLNSLS CCEEEECHHHHHHCC | 47.77 | 21906983 | |
766 | Phosphorylation | EEKDFLNSLSPSTSP ECHHHHHHCCCCCCC | 32.16 | 22199227 | |
768 | Phosphorylation | KDFLNSLSPSTSPTS HHHHHHCCCCCCCCC | 19.34 | 22199227 | |
770 | Phosphorylation | FLNSLSPSTSPTSTP HHHHCCCCCCCCCCC | 37.83 | 22199227 | |
771 | Phosphorylation | LNSLSPSTSPTSTPY HHHCCCCCCCCCCCE | 41.95 | 22199227 | |
772 | Phosphorylation | NSLSPSTSPTSTPYL HHCCCCCCCCCCCEE | 30.44 | 22199227 | |
774 | Phosphorylation | LSPSTSPTSTPYLLF CCCCCCCCCCCEEEE | 45.03 | 22199227 | |
775 | Phosphorylation | SPSTSPTSTPYLLFY CCCCCCCCCCEEEEE | 30.67 | 22199227 | |
776 | Phosphorylation | PSTSPTSTPYLLFYK CCCCCCCCCEEEEEE | 20.59 | 23090842 | |
778 | Phosphorylation | TSPTSTPYLLFYKKL CCCCCCCEEEEEECC | 19.00 | 23090842 | |
782 | Phosphorylation | STPYLLFYKKL---- CCCEEEEEECC---- | 13.74 | 23090842 | |
783 | Ubiquitination | TPYLLFYKKL----- CCEEEEEECC----- | 40.02 | 21890473 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; SER-313 AND SER-475,AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. |